Search research articles
Contact Us
Filters
Showing results (21-30 of 167) with videos related to
Page
of 17
Sort By:
Therapeutic Drug Monitoring
|
February 2, 2023
Successful and Safe Real-Time TDM-Guided Treatment of Invasive Pulmonary and Cerebral Aspergillosis Using Low-Dose Isavuconazole in a Patient with Primary Biliary Cirrhosis: Grand Round/A Case Study
Pier Giorgio Cojutti, Matteo Rinaldi, Maddalena Giannella, et al.
Antibiotics (Basel, Switzerland)
|
December 23, 2022
Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant <i>Pseudomonas aeruginosa</i> Bloodstream Infections and/or Hospital-Acquired Pneumonia
Milo Gatti, Maddalena Giannella, Matteo Rinaldi, et al.
Antibiotics (Basel, Switzerland)
|
December 23, 2023
Could an Optimized Joint Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam Be a Valuable Innovative Approach for Maximizing the Effectiveness of Monotherapy Even in the Treatment of Critically Ill Patients with Documented Extended-Spectrum Beta-Lactamase-Producing <i>Enterobacterales</i> Bloodstream Infections and/or Ventilator-Associated Pneumonia?
Milo Gatti, Matteo Rinaldi, Tommaso Tonetti, et al.
International Journal of Antimicrobial Agents
|
February 7, 2024
Novel CMY-186 variant conferring cross-resistance to cefiderocol and ceftazidime/avibactam in Klebsiella pneumoniae from a critically ill patient during cefiderocol and ceftazidime/avibactam treatment
Stefano Amadesi, Milo Gatti, Matteo Rinaldi, et al.
Journal of Global Antimicrobial Resistance
|
June 3, 2023
Pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam in peritoneal fluid in an orthotopic liver transplant recipient affected by bacteraemic complicated intra-abdominal infection due to OXA-181-producing Klebsiella pneumoniae
Milo Gatti, Matteo Rinaldi, Paolo Gaibani, et al.
Micromachines
|
March 29, 2023
Study of the Performance Enhancement of Sc-Doped AlN Super High Frequency Cross-Sectional Lamé Mode Resonators
Meruyert Assylbekova, Michele Pirro, Xuanyi Zhao, et al.
Nature Communications
|
April 16, 2016
Plasmonic piezoelectric nanomechanical resonator for spectrally selective infrared sensing
Yu Hui, Juan Sebastian Gomez-Diaz, Zhenyun Qian, et al.
Antibiotics (Basel, Switzerland)
|
April 26, 2024
Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP
Milo Gatti, Matteo Rinaldi, Tommaso Tonetti, et al.
Diagnostic Microbiology and Infectious Disease
|
June 14, 2024
In vivo emergence of cefiderocol and ceftazidime/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime/avibactam -based therapies
Stefano Amadesi, Alberto Amedeo, Matteo Rinaldi, et al.
Nature Communications
|
April 2, 2024
Passive frequency comb generation at radiofrequency for ranging applications
Hussein M E Hussein, Seunghwi Kim, Matteo Rinaldi, et al.
Page
of 17
Search research articles
Search
Showing results (21-30 of 167) with videos related to
Sort By:
Page
of 17
Therapeutic Drug Monitoring
|
February 2, 2023
Successful and Safe Real-Time TDM-Guided Treatment of Invasive Pulmonary and Cerebral Aspergillosis Using Low-Dose Isavuconazole in a Patient with Primary Biliary Cirrhosis: Grand Round/A Case Study
Pier Giorgio Cojutti, Matteo Rinaldi, Maddalena Giannella, et al.
Antibiotics (Basel, Switzerland)
|
December 23, 2022
Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant <i>Pseudomonas aeruginosa</i> Bloodstream Infections and/or Hospital-Acquired Pneumonia
Milo Gatti, Maddalena Giannella, Matteo Rinaldi, et al.
Antibiotics (Basel, Switzerland)
|
December 23, 2023
Could an Optimized Joint Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam Be a Valuable Innovative Approach for Maximizing the Effectiveness of Monotherapy Even in the Treatment of Critically Ill Patients with Documented Extended-Spectrum Beta-Lactamase-Producing <i>Enterobacterales</i> Bloodstream Infections and/or Ventilator-Associated Pneumonia?
Milo Gatti, Matteo Rinaldi, Tommaso Tonetti, et al.
International Journal of Antimicrobial Agents
|
February 7, 2024
Novel CMY-186 variant conferring cross-resistance to cefiderocol and ceftazidime/avibactam in Klebsiella pneumoniae from a critically ill patient during cefiderocol and ceftazidime/avibactam treatment
Stefano Amadesi, Milo Gatti, Matteo Rinaldi, et al.
Journal of Global Antimicrobial Resistance
|
June 3, 2023
Pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam in peritoneal fluid in an orthotopic liver transplant recipient affected by bacteraemic complicated intra-abdominal infection due to OXA-181-producing Klebsiella pneumoniae
Milo Gatti, Matteo Rinaldi, Paolo Gaibani, et al.
Micromachines
|
March 29, 2023
Study of the Performance Enhancement of Sc-Doped AlN Super High Frequency Cross-Sectional Lamé Mode Resonators
Meruyert Assylbekova, Michele Pirro, Xuanyi Zhao, et al.
Nature Communications
|
April 16, 2016
Plasmonic piezoelectric nanomechanical resonator for spectrally selective infrared sensing
Yu Hui, Juan Sebastian Gomez-Diaz, Zhenyun Qian, et al.
Antibiotics (Basel, Switzerland)
|
April 26, 2024
Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP
Milo Gatti, Matteo Rinaldi, Tommaso Tonetti, et al.
Diagnostic Microbiology and Infectious Disease
|
June 14, 2024
In vivo emergence of cefiderocol and ceftazidime/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime/avibactam -based therapies
Stefano Amadesi, Alberto Amedeo, Matteo Rinaldi, et al.
Nature Communications
|
April 2, 2024
Passive frequency comb generation at radiofrequency for ranging applications
Hussein M E Hussein, Seunghwi Kim, Matteo Rinaldi, et al.
Page
of 17